Patents-Review.com
ClassID:

110878 ⎘

C12N2760/18034 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260115273
2026-04-30

VIRUS ATTENUATION

 #2
20260108595
2026-04-23

BETACORONAVIRUS mRNA VACCINES

 #3
20260097110
2026-04-09

BETACORONAVIRUS mRNA VACCINES

 #4
20260000750
2026-01-01

RSV VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF

 #5
20250223572
2025-07-10

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

 #6
20250213674
2025-07-03

VIRAL VECTORS

 #7
20250127872
2025-04-24

RECOMBINANT LIVE ATTENUATED RSV VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

 #8
20250121221
2025-04-17

BETACORONA VIRUS mRNA VACCINES

 #9
20250121220
2025-04-17

BETACORONAVIRUS mRNA VACCINES

 #10
20250032601
2025-01-30

METHODS OF MAKING AND USING UNIVERSAL CENTRALIZED INFLUENZA VACCINE GENES

 #11
20240390477
2024-11-28

J PARAMYXOVIRUS VACCINES

 #12
20240366749
2024-11-07

COMBINATION HMPV/RSV RNA VACCINES

 #13
20240366748
2024-11-07

Betacoronavirus RNA vaccines

 #14
20240350617
2024-10-24

COMBINATION HMPV/RSV RNA VACCINES

 #15
20240335526
2024-10-10

COMBINATION HMPV/RSV RNA VACCINES

 #16
20230078668
2023-03-16

Methods of vaccine administration

 #17
20220347295
2022-11-03

Vaccine delivery method

 #18
20220306697
2022-09-29

Self-Assembling Protein Nanostructures Displaying Paramyxovirus and/or Pneumovirus F Proteins and Their Use

 #19
20220267740
2022-08-25

Paramyxovirus virus-like particles as protein delivery vehicles

 #20
20220184204
2022-06-16

Self-assembled protein nanoparticle and its applications thereof

 #21
20220162567
2022-05-26

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

 #22
20220127309
2022-04-28

Chimeric molecules and uses thereof

 #23
20220054626
2022-02-24

Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof

 #24
20210401969
2021-12-30

RSV VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF

 #25
20210386850
2021-12-16

FUSION PROTEIN

 #26
20210353738
2021-11-18

Methods of making and using universal centralized influenza vaccine genes

 #27
20210228627
2021-07-29

FUSOSOME COMPOSITIONS AND USES THEREOF

 #28
20210040502
2021-02-11

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

 #29
20210015916
2021-01-21

Vaccine delivery method

 #30
20200405844
2020-12-31

Combination HMPV/RSV RNA vaccines

 #31
20200377908
2020-12-03

Parainfluenza virus 5 based vaccines

 #32
20200368346
2020-11-26

Liquid vaccines of live enveloped viruses

 #33
20200316192
2020-10-08

Methods of vaccine administration

 #34
20200282046
2020-09-10

Betacoronavirus mRNA vaccine

 #35
20200261566
2020-08-20

Porcine parainfluenza virus compositions and related methods

 #36
20200206339
2020-07-02

Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom

 #37
20200197510
2020-06-25

Betacoronavirus mRNA vaccine

 #38
20200040042
2020-02-06

Chimeric molecules and uses thereof

 #39
20190338253
2019-11-07

Paramyxovirus virus-like particles as protein delivery vehicles

 #40
20190284578
2019-09-19

PIV5 AS AN ONCOLYTIC AGENT

 #41
20190240317
2019-08-08

HPIV3 RNA vaccines

 #42
20190216917
2019-07-18

hMPV RNA vaccines

 #43
20190203186
2019-07-04

Production of viruses in avian eggs

 #44
20190055579
2019-02-21

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

 #45
20180340154
2018-11-29

Production of viruses in avian eggs

 #46
20180326045
2018-11-15

Combination PIV3/hMPV RNA vaccines

 #47
20170360919
2017-12-21

Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine

 #48
20170327845
2017-11-16

PIV5 as an oncolytic agent

 #49
20170224807
2017-08-10

Newcastle disease virus vectored avian vaccines

 #50
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #51
20170175086
2017-06-22

Paramyxovirus virus-like particles as protein delivery vehicles

 #52
20170072046
2017-03-16

Immunogenic composition

 #53
20170067080
2017-03-09

Parainfluenza virus 5 based vaccines

 #54
20170007695
2017-01-12

Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex

 #55
20160279227
2016-09-29

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

 #56
20160237123
2016-08-18

Compositions and methods comprising hydrocarbon-stapled polypeptides

 #57
20160228369
2016-08-11

Dry formulations of vaccines that are room temperature stable

 #58
20160152667
2016-06-02

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS

 #59
20160030556
2016-02-04

Bovine virus vaccines that are liquid stable

 #60
20150344528
2015-12-03

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

 #61
20150246114
2015-09-03

Liquid stable virus vaccines

 #62
20150209422
2015-07-30

Immunization with rabies virus vector expressing foreign protein antigen

 #63
20150182619
2015-07-02

Methods of vaccine administration

 #64
20150086588
2015-03-26

Parainfluenza virus 5 based vaccines

 #65
20150044248
2015-02-12

POLYPEPTIDES AND THEIR USE IN TREATING METAPNEUMOVIRUS (MPV) INFECTION

 #66
20140370050
2014-12-18

PIV5 as oncolytic agent

 #67
20140314717
2014-10-23

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

 #68
20140271711
2014-09-18

Adenoviral vector-based respiratory syncytial virus (RSV) vaccine

 #69
20140271709
2014-09-18

Bovine virus vaccines that are liquid stable

 #70
20140234358
2014-08-21

Newcastle disease virus vectored avian vaccines

 #71
20140056942
2014-02-27

Liquid stable virus vaccines

 #72
20130302360
2013-11-14

Mucosal adjuvant composition

 #73
20130101619
2013-04-25

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

 #74
20130064867
2013-03-14

Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine

 #75
20120269846
2012-10-25

Adjuvanted rabies vaccine with improved viscosity profile

 #76
20120258134
2012-10-11

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #77
20110318352
2011-12-29

Compositions and methods for the treatment of viral infections

 #78
20100255029
2010-10-07

Newcastle disease virus vectored avian vaccines

 #79
20100233785
2010-09-16

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

 #80
20100158942
2010-06-24

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

 #81
20100028379
2010-02-04

METHODS OF VACCINE ADMINISTRATION

 #82
20090203114
2009-08-13

Methods for the propagation of modified influenza viruses in embryonated eggs

 #83
20090053264
2009-02-26

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #84
20080226670
2008-09-18

Canine combination vaccines

 #85
20080175860
2008-07-24

CANINE VACCINES

 #86
20050089533
2005-04-28

Canine vaccines against Bordetella bronchiseptica

 #87
20050054074
2005-03-10

Methods and interferon deficient substrates for the propagation of viruses